| Maier, Elmar (EM Biotech 2009– CEO + Founder before iOmx Therapeutics + GPC Biotech) |
Chief Executive Officer (CEO) |
|
München (Munich) |
| Pejowski, David (Adoram Therapeutics 202210 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland_oo |
| Schubert, Thomas (2bind GbmH 202209 CEO) |
Chief Executive Officer (CEO) |
2bind GmbH |
Regensburg |
| Haerst, Miriam (Kumovis 202005 Managing Director + Co-Founder) |
Managing Director |
3D Systems (Group) |
München (Munich) |
| Killer, Stefan (Kumovis 202005 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
3D Systems (Group) |
München (Munich) |
| Leonhardt, Stefan (Kumovis 202005 Managing Director + Co-Founder) |
Managing Director |
3D Systems (Group) |
München (Munich) |
| Friese, L. |
n. a. |
3i (Group) |
München (Munich) |
| Groenewegen, Frederik (415 Capital 202209 General Partner) |
General Partner (venture partner) |
415 Capital Management GmbH |
München (Munich) |
| Parhizgar, Azin (415 Capital 202404 Senior Venture Partner + Board Chair of Protembis 202403) |
Venture Partner |
415 Capital Management GmbH |
München (Munich) |
| Ammendola, Aldo (4SC 2010– Director Strategic Planning + Regulatory Affairs before Director Developm + QuaNova) |
Business Development Manager / Strategy Manager |
4SC (Group) |
Martinsried |
| Baumgartner, Roland (4SC 201610– promoted CSO joined 2002) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Martinsried |
| Danhauser-Riedl, Susanne (4SC 201401– CMO before GSK GmbH + MedacSchering Onkologie GmbH) |
Chief Medical Officer (CMO) |
4SC (Group) |
Martinsried |
| Enghofer, Erich (4SC 201406– EVP Oncology + Haematology before Bayer Healthcare) |
President/Director/Head Business Group/Unit/Division |
4SC (Group) |
Martinsried |
| Hentsch, Bernd (4SC 201009–201403 Chief Development Officer LEFT 3/14) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
4SC (Group) |
Martinsried |
| Keilhauer, Gerhard (Lipid Therapeutics 201509 before 4SC) |
n. a. |
4SC (Group) |
Martinsried |
| Loveridge, Jason (4SC 201609– CEO) |
Chief Executive Officer (CEO) |
4SC (Group) |
Martinsried |
| von Klitzing, Bettina (4SC 200901 Manager Public Realtions + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Martinsried |
| Ottenberg, Karsten (AATec Medical 202307 Board Chair + Co-Founder) |
Board member, non-executive |
AATec Medical GmbH |
Hohenbrunn |
| Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen) |
Managing Director |
Abalos Therapeutics GmbH |
Düsseldorf |
| Vogt, Joachim (AbbvVie 201809– Director Search + Evaluation Intl before Roche + eADMET + Wilex) |
Business Development Manager / Strategy Manager |
AbbVie (Group) |
Ludwigshafen |
| Arth, Hans-Lothar (ABK Patent and Trademark Attorneys before Axxima) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Martinsried |
| Stahlberg, Dirk (ACURIS Rechtsanwälte 200902) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Martinsried |
| Schotters, Markus (Aceos GmbH 201104 Managing Director) |
Managing Director |
Aceos GmbH |
Fürth |
| Plümpe, Jörg (Active Motif Chromeon GmbH 200901) |
n. a. |
Active Motif (Group) |
Tegernheim |
| Baiker, Wolfgang (Adrenomed 202101–202203 CEO + Venture Partner at Wellington Partners before Boehringer Ingelheim LEFT) |
Chief Executive Officer (CEO) |
Adrenomed AG |
Hennigsdorf |
| Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
Chief Executive Officer (CEO) |
Affectis Pharmaceuticals AG |
Dortmund |
| Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
Chief Medical Officer (CMO) |
Affectis Pharmaceuticals AG |
Dortmund |
| Ammon (formerly Alexandru), Anca (Ammon Communications 202103 before MorphoSys + Affimed + MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Heidelberg |
| Buth, Ines-Regina (akampion 200901 before Micromet Head Investor Relations before Lion Bioscience) |
Public Relations Manager / Investor Relations Manager |
Akampion |
Berlin |
| Lehrke, Ingo (Algiax Pharmaceuticals 2019– CEO + Tubulis 202007 CBO) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Erkrath |
| Heinrich, Peter (Alira Health 202005 Partner + Sinfonie LS 201206– Managing Director before MagForce + MediGene) |
Managing Director |
Alira Health (CMC Consulting Boston) (Group) |
München (Munich) |
| Fließbach, Holger (Alopex 200507– Managing Director) |
Managing Director |
Alopex GmbH |
Kulmbach |
| Thelen, Tobias (Altmann Analytik 201312 Managing Director) |
Managing Director |
Altmann Analytik (Group) |
München (Munich) |
| Förster, Borris (Amathaon Capital 202110 Managing Director + Co-Founder) |
Managing Director |
Amathaon Capital UG (haftungsbeschränkt) |
München (Munich) |
| Schönhaar, Tobias (Amathaon Capital 202110 Managing Director + Co-Founder) |
Managing Director |
Amathaon Capital UG (haftungsbeschränkt) |
München (Munich) |
| Grau, Ulrich (Micromet 201106–2012 COO before Lux Biosciences CEO before Enzon 2002–2005 CSO before BASF/Knoll) |
Chief Operating Officer (COO) |
Amgen (Group) |
München (Munich) |
| Reisenauer, Mark (Micromet 200709– Senior VP + CCO) |
n. a. |
Amgen (Group) |
München (Munich) |
| Wassill, Lars (AmplexDiagnostics 200810) |
n. a. |
AmplexDiagnostics GmbH |
Markt Gars a. Inn |
| Kehl, Anja (AMSilk 202105 Public Relations) |
Public Relations Manager / Investor Relations Manager |
AMSilk GmbH |
Martinsried |
| Leimer, Axel (AMSilk 201103 Managing Director) |
Managing Director |
AMSilk GmbH |
Martinsried |
| Rosenberger, Isabel (AMSilk 202304 Seior Manager Marketing + Communications) |
Sales Manager / Marketing Manager |
AMSilk GmbH |
Martinsried |
| Scherbel, Ulrich (AMSilk 202101– CEO joined as COO 202010 before Global Apparel Division of Freudenberg) |
Chief Executive Officer (CEO) |
AMSilk GmbH |
Martinsried |
| Wagner-Solbach, Volker (AMSilk 201704– Procurement + Supply Chain Manager before AVA-CO2 AG + Bayern Innovativ GmbH) |
management (personnel) |
AMSilk GmbH |
Martinsried |
| Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) |
Business Development Manager / Strategy Manager |
AMSilk GmbH |
Martinsried |
| Klosterkemper, Bernd (Ananda Ventures 201908) |
Investment Manager |
Ananda Ventures GmbH (Ananda Impact Ventures) |
München (Munich) |
| Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) |
Chief Executive Officer (CEO) |
Anavo Therapeutics (Group) |
Leiden |
| Litzka, Olivier (Andera Partners 202104 Partner Life Sciences + Coordinator DACH before EdRIP + 3i Venture Healthcare) |
Partner (venture partner) |
Andera Partners (FR) |
München (Munich) |
| Angermayer, Christian (Apeiron Investment 202010 Founder formerly Co-founder of Ribopharma) |
Company Founder |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta_oo |
| Niebling, Anna (AntiProt GmbH 2007) |
n. a. |
AntiProt GmbH |
Martinsried |
| Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Wien (Vienna) |
| Fricke, Harald (Apogenix GmbH 200511– CMO + COO before Fresenius Biotech + Baxter + GSK) |
Chief Medical Officer (CMO) |
Apogenix AG |
Heidelberg |
| Buhmann, Raymund (AptaIT GmbH 201707 Managing Director) |
Managing Director |
AptaIT GmbH |
Martinsried |
| Rüdiger, Manfred (Ariceum Therapeutics 202206 CEO before Catalym + Affectis + Kiadis Pharma + LSP Munich) |
Chief Executive Officer (CEO) |
Ariceum Therapeutics (Group) |
Berlin |
| Schwandner, Wolfgang (Arnika Beteiligungen 201703 Managing Director) |
Managing Director |
Arnika Beteiligungen GmbH (family office) |
München (Munich) |
| Schneider, G. F. (Astellas Pharma GmbH 200512 Director Licensing + Sales) |
IP Manager |
Astellas (Group) |
München (Munich) |
| Arechiga, Adrian (AstraZeneca 201809 Media Contact at Definiens AG) |
Public Relations Manager / Investor Relations Manager |
AstraZeneca (Group) |
München (Munich) |
| Baatz, Martin (Definiens 201104 VP Marketing) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
München (Munich) |
| Berghorn, Rebecca (Definiens 201310– Director Clinical Product Marketing before MeVis Medical) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
München (Munich) |
| Binnig, Gerd (Definiens 201210 CTO + Co-founder + Nobel Laureate) |
Chief Technology/Technical Officer (CTO) |
AstraZeneca (Group) |
München (Munich) |
| Calaman, Greg (Definiens 200604– VP North America Operations) |
n. a. |
AstraZeneca (Group) |
München (Munich) |
| Dey, Neil (Definiens 200507– joined from Bioimagene) |
n. a. |
AstraZeneca (Group) |
München (Munich) |
| Hartmann, Kai (Definiens 201305 Director Product Marketing Life Sciences) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
München (Munich) |
| Hermes, Rene (Definiens AG 200611 Vice Pres Marketing) |
n. a. |
AstraZeneca (Group) |
München (Munich) |
| Heydler, Thomas P. (Definiens 200411– CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
München (Munich) |
| Jordan, Pablo (Definiens 201310– VP Business Development Clinical Digital Pathology before bioMérieux + Ventana) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
München (Munich) |
| Klein, Frank-P. (Definiens 200811 VP Medical Imaging) |
n. a. |
AstraZeneca (Group) |
München (Munich) |
| Lehner, Oliver (AstraZeneca 201809 VP Business Development + Partnering at Definiens AG) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
München (Munich) |
| Neeleman, Christiaan (Definiens 201309– COO before among others Philips Healthcare) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
München (Munich) |
| Oehl, Heinz (AstraZeneca 201707– VP Global Marketing + Corp Business Development at Definiens) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
München (Munich) |
| Rasche, Michael (AstraZeneca 201707– promoted CCO at Definiens joined 201602 as SVP Global Sales before Ayoxxa + Dako) |
Chief Commercial Officer (CCO) |
AstraZeneca (Group) |
München (Munich) |
| Schunk, Markus (AstraZeneca 201809– COO at Definiens before CEO at Holtzbrinck Digital joined Holtzbrinck 2004 + KPMG) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
München (Munich) |
| Stuart, Martin (Definiens 201201– EVP + General Manager North America + Asia Pacific before Aperio + Entropia) |
Regional manager |
AstraZeneca (Group) |
München (Munich) |
| Voglmaier, Manfred (Definiens –200411–200810 VP BusDev Life Sciences) |
Business Development Manager / Strategy Manager |
AstraZeneca (Group) |
München (Munich) |
| Brand, Florian (ATAI Life Sciences 202004 CEO) |
Chief Executive Officer (CEO) |
Atai Life Sciences AG |
München (Munich) |
| Lichtenberger, Rainer (Atriva 201606–2023 CEO + Co-Founder before Cevec + Merckle/ratiopharm + Merck KGaA RETIRED 2023) |
Chief Executive Officer (CEO) |
Atriva Therapeutics GmbH |
Martinsried |
| Wallasch, Christian (Atriva Therapeutics 201901 COO before Axxima + U3 + Intercell/Valneva) |
Chief Operating Officer (COO) |
Atriva Therapeutics GmbH |
Martinsried |
| Hager, Gerhard (Aurigon Life Science GmbH 201412 Managing Director) |
Managing Director |
Aurigon Life Science GmbH |
Tutzing |
| Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) |
Chief Executive Officer (CEO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
London, Greater London |
| Bundis, Florian (Peqlab 200809) |
n. a. |
Avantor (Group) |
Erlangen |
| Hardung, Kerstin (Peqlab 200809) |
n. a. |
Avantor (Group) |
Erlangen |
| Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Erlangen |
| Mischau, Reinhold (Peqlab Biotechnologie GmbH 200710 Managing Director) |
Managing Director |
Avantor (Group) |
Erlangen |
| Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) |
Managing Director |
Avergen Pharmaceuticals GmbH (APG) |
Martinsried |
| Kley, Julian (Avi Medical 202204 Managing Director (COO) + Co-Founder) |
Managing Director |
Avi Medical (Group) |
München (Munich) |
| Lata, Vlad (Avi Medical 202204 Managing Director (CEO) + Co-Founder) |
Managing Director |
Avi Medical (Group) |
München (Munich) |
| Baron, Oliver (Aviru GmbH 201104 Managing Director) |
Managing Director |
Aviru GmbH |
München (Munich) |
| Barth, Wolfgang (Avontec 200402– joined from Bayer Pharmaceuticals) |
n. a. |
Avontec GmbH |
Martinsried |
| Grupe, Helga (Avontec 200709– Managing Director+ CBO before 2000–2007 VP BusDev Wilex AG before Monsanto Deutschland) |
Managing Director |
Avontec GmbH |
Martinsried |
| Niederfeld, Thomas (Avontec 200404– joined from Carl Zeiss) |
n. a. |
Avontec GmbH |
Martinsried |
| Schulze, Thomas (FundaMental Pharma 202106 CEO + Co-Founder formerly Avontec + november AG + Bayer AG) |
Managing Director |
Avontec GmbH |
Martinsried |
| Kaltenhauser, Ulrike (BayGene 201110 Managing Director) |
Managing Director |
AW-Biotech-Marketing – Dr. Andrea Wetzel |
München (Munich) |
| Reitberger, Christian (btov Partners 202011 Partner) |
Partner (venture partner) |
b-to-v Partners AG (btov Partners) |
München (Munich) |
| Klingan, Franz-Robert (Bain & Co 201610 Partner) |
Consultant (economic/technology) |
Bain & Company |
|
| Hummel, Berthold (Baker McKenzie 202106 before Dechert) |
Attorney / Lawyer |
Baker McKenzie LLP |
Chicago, IL |
| Aiwanger, Hubert (Bavaria (govt) 201904 State Minister of Economic Affairs + Regional Development + Energy) |
Minister |
Bavaria (govt region) |
München (Munich) |
| Burgstaller, Petra (BioM 202001 Senior Manager Start-ups + Funding) |
Cluster Manager |
Bavaria (govt region) |
Martinsried |
| Dengler, Wolfgang (Bavaria (govt) 201410 Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Landshut |
| Domdey, Horst (BioM 1997–202212 Managing Director RETIRED 12/22) |
Cluster Manager |
Bavaria (govt region) |
Martinsried |
| Gnam, Christian (Bavaria (govt) 202404– Managing Director IZB before InsurTech Hub Munich + Invest in Bavaria) |
Managing Director |
Bavaria (govt region) |
Martinsried |
| Graf, Peter (Bavaria (govt) 201902 Investment Manager at BayBG) |
Investment Manager |
Bavaria (govt region) |
München (Munich) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
